Mifepristone abortion capsule case earlier than Courtroom of Enchantment

Mifepristone, the first drug in a medical abortion, is prepared for a patient April 20, 2023 at the Alamo Women’s Clinic in Carbondale, Illinois. Evelyn Hockstein Reuters A federal appeals court Wednesday afternoon will hear arguments in a closely watched lawsuit aimed at removing the abortion pill mifepristone from the US market. The hearing in …

Google Cloud introduces AI instruments to speed up drug discovery

A person walks next to the Google Cloud logo at the Mobile World Congress (MWC) in Barcelona, ​​Spain, on February 27, 2023. Sweet Nacho | Reuters Google Cloud on Tuesday launched two new AI-powered tools designed to help biotech and pharmaceutical companies accelerate drug discovery and advance precision medicine. A tool called the Target and …

Common flu vaccine based mostly on mRNA expertise to be examined by NIH

A woman receives a booster dose of Moderna coronavirus vaccine (COVID-19) at a vaccination center in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters The National Institutes of Health announced Monday that patients are now enrolling in an early clinical trial to test a universal influenza vaccine based on messenger RNA technology. Scientists hope …

Free Covid vaccinations for the uninsured following a public well being emergency

A health care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a immunization clinic at the Peabody Institute Library in Peabody, Massachusetts on Wednesday, January 26, 2022. Vanessa Leroy | Bloomberg | Getty Images For now, uninsured Americans will continue to have free access to Covid-19 vaccines even after the US public health …

Most People do not get publicity alerts on their cell telephones

In most states, Americans will no longer receive notifications of a Covid infection on their smartphones after the end of the US public health emergency. As of 2020, almost 30 countries are using a Bluetooth system developed by Apple And Google to track the spread of Covid infections and to send push notifications to all …

Leqembi might value Medicare $5 billion a 12 months

Alzheimer’s drug Leqembi can be seen in this undated handout picture obtained by Reuters on January 20, 2023. Eisai | Reuters New Alzheimer’s antibody treatment Leqembi could cost Medicare up to $5 billion a year, according to a study published this week in a leading medical journal. Medicare would spend about $2 billion a year …

In response to the WHO, the outbreak is not a worldwide well being emergency

Pharmacist Uchita Parikh prepares a dose of the Jynneos monkeypox vaccine at a pop-up immunization clinic opened by the Los Angeles County Department of Public Health today, August 3, 2022 at the West Hollywood Library in West Hollywood, California. Mario Tama | Getty Images The World Health Organization on Thursday declared the global public health …

The US public well being Covid emergency is ending

A sign outside a hospital advertises COVID-19 testing on November 19, 2021 in New York City. Spencer Platt | Getty Images The public health emergency in the United States, declared in response to Covid-19, ends on Thursday, more than three years after the pandemic began. The Biden administration’s decision to end the state of emergency …

Eli Lilly guarantees insulin costs will not go up; Novo Nordisk, Sanofi hedge

An Eli Lilly & Co. logo is featured on a box of insulin medications in this arranged photo of a pharmacy in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Eli Lilli CEO Dave Ricks vowed Wednesday not to raise prices again on the company’s existing insulin products — the only executive to do …

The FDA appears skeptical concerning the push for the over-the-counter contraception capsule

Opill oral contraception Source: dog The Food and Drug Administration on Tuesday raised significant concerns about a drugmaker’s application to sell a birth control pill without a prescription. A panel of independent experts advising the FDA is meeting Tuesday and Wednesday to make a recommendation on whether data presented by HRA Pharma is sufficient to …